Image 1
Chemical structure of Doxazosin Mesylate, the active ingredient in the Doxazosin tablets produced by Teva Pharmaceuticals USA, Inc.*
Doxazosin Tablet
Product Images NDC 0093-2069
7 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 0093-2069). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
A table presenting symptom scores and maximum flow rate data from three clinical studies evaluating doxazosin mesylate in doses up to 8 mg. The table shows mean baseline values and mean changes compared to placebo, including significance levels. The right side includes a bar graph illustrating maximum flow rate and symptom score changes for placebo, 4 mg, and 8 mg doses from Study 2.*
Image 3
Two line charts showing clinical data for Doxazosin Mesylate versus placebo over 14 weeks. The top chart displays mean change in total symptom score from baseline, with Doxazosin Mesylate showing greater reduction than placebo. The bottom chart shows mean increase in maximum urinary flow rate, with Doxazosin Mesylate demonstrating higher flow rate improvement compared to placebo. Statistical significance is noted for Doxazosin Mesylate at multiple time points.*
Image 4
Doxazosin Tablets USP 1 mg tablet label by Teva Pharmaceuticals USA, Inc. This prescription oral tablet label states each tablet contains 1 mg doxazosin mesylate as the free base. The label indicates a package size of 100 tablets and includes storage instructions, manufacturer details, and a barcode. It is marked Rx only.*
Image 5
Label for Doxazosin Tablets USP 2 mg, oral tablets, supplied in a 100-tablet container. The label displays the dosage strength prominently in red, NDC number 0093-2069-01, and is manufactured for Teva Pharmaceuticals USA, Inc. Additional storage instructions and manufacturing details are also present.*
Image 6
Doxazosin Tablets USP 4 mg carton label from Teva Pharmaceuticals USA, Inc. The label states each tablet contains doxazosin mesylate equivalent to 4 mg doxazosin as the active ingredient. The package contains 100 tablets for oral use. Storage instructions and manufacturer details are also shown, including lot number and manufacturing site in India.*
Image 7
Doxazosin Tablets USP 8 mg label from Teva Pharmaceuticals USA, Inc. The label includes dosage strength 8 mg, quantity of 100 tablets, and instructions to keep the medication in a well-closed container at 20 to 25 degrees Celsius. It notes the generic name, doxazosin mesylate equivalent to 8 mg doxazosin base, and contains storage, dispensing, and manufacturing details, including manufacturing by a site in India.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
